The Clock Drawing Test as a predictor of cognitive decline in non-demented stroke patients.
Clock Drawing Test
Post-stroke cognitive impairment
Post-stroke dementia
Predictivity
Stroke
Journal
Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161
Informations de publication
Date de publication:
Jan 2022
Jan 2022
Historique:
received:
15
04
2021
accepted:
31
05
2021
revised:
28
05
2021
pubmed:
8
6
2021
medline:
11
1
2022
entrez:
7
6
2021
Statut:
ppublish
Résumé
The early detection of patients at risk of post-stroke cognitive impairment (PSCI) may help planning subacute and long-term care. We aimed to determine the predictivity of two screening cognitive tests on the occurrence of mild cognitive impairment or dementia in acute stroke patients. A cognitive assessment within a few days of ischemic or hemorrhagic stroke was performed in patients consecutively admitted to a stroke unit over 14 months by means of the Clock Drawing Test (CDT) and the Montreal Cognitive Assessment-Basic (MoCA-B). Out of 191 stroke survivors who were non-demented at baseline, 168 attended at least one follow-up visit. At follow-up (mean duration ± SD 12.8 ± 8.7 months), 28 (18.9%) incident cases of MCI and 27 (18%) cases of dementia were recorded. In comparison with patients who remained cognitively stable at follow-up, these patients were older, less educated, had more comorbidities, a higher score on the National Institutes of Health Stroke Scale (NIHSS) at admission, more severe cerebral atrophy, and lower MoCA-B and CDT scores at baseline. In multi-adjusted (for age, education, comorbidities score, NIHSS at admission and atrophy score) model, a pathological score on baseline CDT (< 6.55) was associated with a higher risk of PSCI at follow-up (HR 2.022; 95% CI 1.025-3.989, p < 0.05) with respect to non-pathological scores. A pathological baseline score on MoCA-B (< 24) did not predict increased risk of cognitive decline at follow-up nor increased predictivity of stand-alone CDT. A bedside cognitive screening with the CDT helps identifying patients at higher risk of PSCI.
Sections du résumé
BACKGROUND
BACKGROUND
The early detection of patients at risk of post-stroke cognitive impairment (PSCI) may help planning subacute and long-term care. We aimed to determine the predictivity of two screening cognitive tests on the occurrence of mild cognitive impairment or dementia in acute stroke patients.
METHODS
METHODS
A cognitive assessment within a few days of ischemic or hemorrhagic stroke was performed in patients consecutively admitted to a stroke unit over 14 months by means of the Clock Drawing Test (CDT) and the Montreal Cognitive Assessment-Basic (MoCA-B).
RESULTS
RESULTS
Out of 191 stroke survivors who were non-demented at baseline, 168 attended at least one follow-up visit. At follow-up (mean duration ± SD 12.8 ± 8.7 months), 28 (18.9%) incident cases of MCI and 27 (18%) cases of dementia were recorded. In comparison with patients who remained cognitively stable at follow-up, these patients were older, less educated, had more comorbidities, a higher score on the National Institutes of Health Stroke Scale (NIHSS) at admission, more severe cerebral atrophy, and lower MoCA-B and CDT scores at baseline. In multi-adjusted (for age, education, comorbidities score, NIHSS at admission and atrophy score) model, a pathological score on baseline CDT (< 6.55) was associated with a higher risk of PSCI at follow-up (HR 2.022; 95% CI 1.025-3.989, p < 0.05) with respect to non-pathological scores. A pathological baseline score on MoCA-B (< 24) did not predict increased risk of cognitive decline at follow-up nor increased predictivity of stand-alone CDT.
CONCLUSION
CONCLUSIONS
A bedside cognitive screening with the CDT helps identifying patients at higher risk of PSCI.
Identifiants
pubmed: 34095964
doi: 10.1007/s00415-021-10637-z
pii: 10.1007/s00415-021-10637-z
pmc: PMC8739305
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
342-349Informations de copyright
© 2021. The Author(s).
Références
Katan M, Luft A (2018) Global burden of stroke. Semin Neurol 38:208–211. https://doi.org/10.1055/s-0038-1649503
doi: 10.1055/s-0038-1649503
pubmed: 29791947
Barbay M, Diouf M, Roussel M et al (2018) Systematic review and meta-analysis of prevalence in post-stroke neurocognitive disorders in hospital-based studies. Dement Geriatr Cogn Disord 46:322–334. https://doi.org/10.1159/000492920
doi: 10.1159/000492920
pubmed: 30504699
Park JH, Kim BJ, Bae H-J et al (2013) Impact of post-stroke cognitive impairment with no dementia on health-related quality of life. J Stroke 15:49. https://doi.org/10.5853/jos.2013.15.1.49
doi: 10.5853/jos.2013.15.1.49
pubmed: 24324939
pmcid: 3779672
Sturm JW, Donnan GA, Dewey HM et al (2004) Quality of life after stroke: the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke 35:2340–2345. https://doi.org/10.1161/01.STR.0000141977.18520.3b
doi: 10.1161/01.STR.0000141977.18520.3b
pubmed: 15331799
Hu G-C, Chen Y-M (2017) Post-stroke dementia: epidemiology, mechanisms and management. Int J Gerontol 11:210–214. https://doi.org/10.1016/j.ijge.2017.07.004
doi: 10.1016/j.ijge.2017.07.004
Eskes GA, Lanctôt KL, Herrmann N et al (2015) Canadian stroke best practice recommendations: mood, cognition and fatigue following stroke practice guidelines, update 2015. Int J Stroke 10:1130–1140. https://doi.org/10.1111/ijs.12557
doi: 10.1111/ijs.12557
pubmed: 26121596
Quinn TJ, Elliott E, Langhorne P (2018) Cognitive and mood assessment tools for use in stroke. Stroke 49:483–490. https://doi.org/10.1161/STROKEAHA.117.016994
doi: 10.1161/STROKEAHA.117.016994
pubmed: 29284733
Stolwyk RJ, O’Neill MH, McKay AJD, Wong DK (2014) Are cognitive screening tools sensitive and specific enough for use after stroke?: A systematic literature review. Stroke 45:3129–3134. https://doi.org/10.1161/STROKEAHA.114.004232
doi: 10.1161/STROKEAHA.114.004232
pubmed: 25074518
Champod AS, Gubitz GJ, Phillips SJ et al (2019) Clock Drawing Test in acute stroke and its relationship with long-term functional and cognitive outcomes. Clin Neuropsychol 33:817–830. https://doi.org/10.1080/13854046.2018.1494307
doi: 10.1080/13854046.2018.1494307
pubmed: 29985104
Julayanont P, Tangwongchai S, Hemrungrojn S et al (2015) The Montreal Cognitive Assessment-Basic: a screening tool for mild cognitive impairment in illiterate and low-educated elderly adults. J Am Geriatr Soc 63:2550–2554. https://doi.org/10.1111/jgs.13820
doi: 10.1111/jgs.13820
pubmed: 26648041
Nasreddine ZS, Phillips NA, Bédirian V, et al (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment: MOCA: a brief screening tool for MCI. J Am Geriatr Soc 53:695–699. https://doi.org/10.1111/j.1532-5415.2005.53221.x
doi: 10.1111/j.1532-5415.2005.53221.x
pubmed: 15817019
Salvi F, Miller MD, Grilli A et al (2008) A manual of guidelines to score the modified cumulative illness rating scale and its validation in acute hospitalized elderly patients. J Am Geriatr Soc 56:1926–1931
doi: 10.1111/j.1532-5415.2008.01935.x
pubmed: 18811613
Brott T, Adams HP, Olinger CP et al (1989) Measurements of acute cerebral infarction: a clinical examination scale. Stroke 20:864–870. https://doi.org/10.1161/01.STR.20.7.864
doi: 10.1161/01.STR.20.7.864
pubmed: 2749846
Farrell B, Godwin J, Richards S, Warlow C (1991) The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry 54:1044–1054. https://doi.org/10.1136/jnnp.54.12.1044
doi: 10.1136/jnnp.54.12.1044
pubmed: 1783914
pmcid: 1014676
Wahlund LO, Barkhof F, Fazekas F et al (2001) A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 32:1318–1322. https://doi.org/10.1161/01.STR.32.6.1318
doi: 10.1161/01.STR.32.6.1318
pubmed: 11387493
Pasquier F, Leys D, Weerts JGE et al (1996) Inter-and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts. Eur Neurol 36:268–272. https://doi.org/10.1159/000117270
doi: 10.1159/000117270
pubmed: 8864706
Katz S, Ford AB, Moskowitz RW et al (1963) Studies of illness in the aged. The index of Adl: a standardized measure of biological and psychosocial function. JAMA 185:914–919
doi: 10.1001/jama.1963.03060120024016
pubmed: 14044222
Lawton MP, Brody EM (1969) Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9:179–186
doi: 10.1093/geront/9.3_Part_1.179
pubmed: 5349366
Hughes CP, Berg L, Danziger WL et al (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140:566–572
doi: 10.1192/bjp.140.6.566
pubmed: 7104545
Morris JC (1993) The clinical dementia rating (CDR): current version and scoring rules. Neurology 43:2412–2412. https://doi.org/10.1212/WNL.43.11.2412-a
doi: 10.1212/WNL.43.11.2412-a
pubmed: 8232972
Caffarra P, Gardini S, Zonato F et al (2011) Italian norms for the Freedman version of the Clock Drawing Test. J Clin Exp Neuropsychol 33:982–988. https://doi.org/10.1080/13803395.2011.589373
doi: 10.1080/13803395.2011.589373
pubmed: 22082081
Spenciere B, Alves H, Charchat-Fichman H (2017) Scoring systems for the Clock Drawing Test: a historical review. Dement Neuropsychol 11:6–14. https://doi.org/10.1590/1980-57642016dn11-010003
doi: 10.1590/1980-57642016dn11-010003
pubmed: 29213488
pmcid: 5619209
Freedman M, Leach L, Kaplan E, Winocur G, Shulman K, Delis DC (1994) Clock Drawing: a neuropsychological analysis. Oxford University Press
Dong Y, Xu J, Chan BP-L et al (2016) The Montreal Cognitive Assessment is superior to National Institute of Neurological Disease and Stroke-Canadian Stroke Network 5-minute protocol in predicting vascular cognitive impairment at 1 year. BMC Neurol 16:46. https://doi.org/10.1186/s12883-016-0570-y
doi: 10.1186/s12883-016-0570-y
pubmed: 27067253
pmcid: 4828765
Jacquin A, Binquet C, Rouaud O et al (2014) Post-stroke cognitive impairment: high prevalence and determining factors in a cohort of mild stroke. J Alzheimers Dis 40:1029–1038. https://doi.org/10.3233/JAD-131580
doi: 10.3233/JAD-131580
pubmed: 24577459
Dong Y, Venketasubramanian N, Chan BP-L et al (2012) Brief screening tests during acute admission in patients with mild stroke are predictive of vascular cognitive impairment 3–6 months after stroke. J Neurol Neurosurg Psychiatry 83:580–585. https://doi.org/10.1136/jnnp-2011-302070
doi: 10.1136/jnnp-2011-302070
pubmed: 22496580
Zietemann V, Georgakis MK, Dondaine T et al (2018) Early MoCA predicts long-term cognitive and functional outcome and mortality after stroke. Neurology 91:e1838–e1850. https://doi.org/10.1212/WNL.0000000000006506
doi: 10.1212/WNL.0000000000006506
pubmed: 30333158
Salvadori E, Pasi M, Poggesi A et al (2013) Predictive value of MoCA in the acute phase of stroke on the diagnosis of mid-term cognitive impairment. J Neurol 260:2220–2227. https://doi.org/10.1007/s00415-013-6962-7
doi: 10.1007/s00415-013-6962-7
pubmed: 23716072
Hachinski V, Iadecola C, Petersen RC et al (2006) National Institute of Neurological Disorders and Stroke-Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards. Stroke 37:2220–2241. https://doi.org/10.1161/01.STR.0000237236.88823.47
doi: 10.1161/01.STR.0000237236.88823.47
pubmed: 16917086